Cutler Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,400
Closed -$6K 5627
2022
Q2
$6K Buy
10,400
+8,700
+512% +$1.03M ﹤0.01% 3630
2022
Q1
$9K Buy
+1,700
New +$205K ﹤0.01% 3728
2021
Q1
Sell
-6,695
Closed -$41K 6422
2020
Q4
$41K Buy
+6,695
New +$946K ﹤0.01% 2146
2018
Q1
Sell
-5,047
Closed -$1K 5355
2017
Q4
$1K Sell
5,047
-26,574
-84% -$3M ﹤0.01% 4630
2017
Q3
$103K Sell
31,621
-11,639
-27% -$1.34M ﹤0.01% 1653
2017
Q2
$219K Buy
43,260
+41,715
+2,700% +$4.95M 0.01% 1203
2017
Q1
$4K Sell
1,545
-10,300
-87% -$1.17M ﹤0.01% 4977
2016
Q4
$13K Sell
11,845
-4,738
-29% -$508K ﹤0.01% 3930
2016
Q3
$118K Sell
16,583
-4,635
-22% -$573K 0.01% 1688
2016
Q2
$102K Sell
21,218
-25,544
-55% -$2.89M 0.01% 1682
2016
Q1
$207K Buy
46,762
+25,029
+115% +$2.42M 0.01% 999
2015
Q4
$15K Buy
+21,733
New +$2.13M ﹤0.01% 3720

Other funds holding ZBH

Cutler Group's ZBH Position: Q2 2023 in Review

Cutler Group sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 195 shares — an estimated $25K sold.

Cutler Group first reported a position in ZBH in Q4 2015 and held it in 17 quarters. The position peaked at $4.51M in Q3 2017. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Cutler Group reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 195 Zimmer Biomet shares in Q2 2023, an estimated $25K.
  • Cutler Group first reported a position in Zimmer Biomet in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Zimmer Biomet position peaked at $4.51M in Q3 2017.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.